Emily Vogtmann, PhD profile page

Dr. Emily Vogtmann received her BS in biochemistry and molecular biology and BA in Spanish from Michigan State University, East Lansing, in 2005. She went on to receive an MPH in international health epidemiology from the University of Michigan, Ann Arbor, in 2009, where she investigated human papillomavirus and cervical cancer awareness and mortality trends in Mexico. Vogtmann completed a PhD in epidemiology in 2013 at the University of Alabama at Birmingham. Her dissertation focused on cruciferous vegetable intake, GST polymorphisms, and colorectal cancer among men in Shanghai, China, completed in collaboration with the Shanghai Cancer Institute and Vanderbilt University Medical Center, Nashville, TN. Vogtmann joined DCEG as a Cancer Prevention Fellow in the Metabolic Epidemiology Branch in August 2013 and was promoted to research fellow in June 2016. She was appointed to the position of Earl Stadtman Investigator in 2018. Vogtmann has received a number of awards for her work, including the NIH and DCEG Fellows’ Award for Research Excellence and the NCI Director’s Innovation Award.